SU162294A1 - - Google Patents
Info
- Publication number
- SU162294A1 SU162294A1 SU807406A SU807406A SU162294A1 SU 162294 A1 SU162294 A1 SU 162294A1 SU 807406 A SU807406 A SU 807406A SU 807406 A SU807406 A SU 807406A SU 162294 A1 SU162294 A1 SU 162294A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- solution
- added
- protein
- vitamins
- sodium
- Prior art date
Links
- 239000000243 solution Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 239000003531 protein hydrolysate Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229960000988 nystatin Drugs 0.000 description 3
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- -1 sodium nucleic acid Chemical class 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Description
Известно применение питательных безбелковых поддерживающих сред дл животных клеток , выращиваемых in vitro, содержащих белковый гидролизат, солевой раствор и витамины . Указанные среды обеспечивают удовлетворительный срок переживани клеток лишь в случае регул рного (два раза в неделю) обновлени среды.It is known to use nutrient protein-free supporting media for animal cells grown in vitro, containing protein hydrolyzate, saline and vitamins. These media provide a satisfactory cell survival time only in the case of regular (twice weekly) medium renewal.
Дл увеличени сроков переживани клеток в питательную безбелковую среду ввод т пуклеиновокислый натрий. Дл приготовлени предлагаемой питательной безбелковой поддерживающей среды асептически смешивают солевой раствор (89,88-89,84%), белковый гидролизат (10,0%), раствор витаминов (0,05%-пый раствор фолиевой кислоты) и раствор нуклеиновокислого натри (0,02- 0,06%).In order to increase the cell survival time, nucleated sodium is introduced into the protein-free nutrient medium. For the preparation of the proposed nutrient-free protein supportive medium, the salt solution (89.88-89.84%), the protein hydrolyzate (10.0%), the solution of vitamins (0.05% folic acid solution), and sodium nucleic acid (0 , 02- 0.06%).
В качестве солевого раствора используют любой из обычно примен емых дл культивировани клеток, например солевой раствор Хенкса или Эрла. В качестве белкового гидролизата можпо использовать стерильные жидкие белковые гидролизаты, примен емые дл парентерального питани больных. Не исключаетс также применение раствора гидролизата лактальбумина и других белковых гидролизатов , если только они содержат все необходимые дл роста клеток аминокислоты.As a saline solution, any of the cells commonly used for culturing is used, for example, Hanks or Earl saline solution. Sterile liquid protein hydrolysates used for parenteral nutrition of patients can be used as a protein hydrolyzate. The use of a solution of lactalbumin hydrolyzate and other protein hydrolysates is also not excluded, as long as they contain all the amino acids necessary for cell growth.
Пример 1. Дл приготовлени раствора Витаминов к 10 мл обессоленной воды добавл ют 2 мл концентрированной сол ной кислоты и 10 мл рибофлавина. Дл полного растворени рибофлавина смесь нагревают на кип ш ,ей вод ной бане. Охлажденный раствор довод т до 100 мл обессоленной водой и добавл ют по 100 мг пиридоксииа (или пиридоксал ), пантотената кальци (или пантотеновой кислоты),тиамина, пиацина и хлорида холина и 200 мезоинзита. После полного растворени всех компонентов раствора его объем довод т до 198 мл химически чистым или перегнанным глицерином и приливают 2 мл 1,7%-ного раствора нистатина в 70%-ном эталоне. Хран т раствор в светонепроницаемой посуде при 15°С. Срок годности 6 мес цев. Употребл ть раствор можно не ранее, чем через 5 дней после его изготовлени .Example 1. To prepare a solution of vitamins, 2 ml of concentrated hydrochloric acid and 10 ml of riboflavin are added to 10 ml of desalted water. To completely dissolve the riboflavin, the mixture is heated in a boiling water bath. The cooled solution is made up to 100 ml with desalted water and 100 mg of pyridoxia (or pyridoxal), calcium pantothenate (or pantothenic acid), thiamine, pyacin and choline chloride and 200 mesoinzite are added. After complete dissolution of all components of the solution, its volume is brought to 198 ml with chemically pure or distilled glycerol and 2 ml of a 1.7% solution of nystatin in a 70% standard are added. Store the solution in an opaque dish at 15 ° C. Shelf life 6 months. The solution can be consumed no earlier than 5 days after its manufacture.
Пример 2. Дл приготовлени раствора фолиевой кислоты к 90 мл обессоленной воды приливают 10 мл 7,5%-ного раствора бикарбоната натри и добавл ют 100 мг фолиевой кислоты , после растворени которой добавл ют 80 мг хлоргидрата тетрациклина. Объем раствора довод т до 198 мл химически чистым глицерином и приливают 2 мл 1,7%-ного раствора нистатина в 70%-ном эталоне. Услови хранени , срок годности и длительности выдерживани перед употреблением те же, что п дл раствора витаминов.Example 2. To prepare a folic acid solution, 10 ml of a 7.5% sodium bicarbonate solution are added to 90 ml of desalted water and 100 mg of folic acid is added, after which 80 mg of tetracycline hydrochloride is added. The volume of the solution is made up to 198 ml with chemically pure glycerol and 2 ml of a 1.7% solution of nystatin in a 70% standard are added. The storage conditions, shelf life and shelf life before consumption are the same as for vitamins.
ПримерЗ. Дл приготовлени раствора нуклеиновокислого натри к 10 мл обессоленной воды прибавл ют 2000 мг соли, после растворени которой довод т объем до 18 мл химически чистым глицерином, и приливают 2 мл раствора нистатина. Услови хранени , срокExample To prepare a solution of nucleic acid sodium, 2000 mg of salt are added to 10 ml of desalted water, after dissolving which the volume is brought to 18 ml with chemically pure glycerin, and 2 ml of nystatin solution is added. Storage conditions, term
годности и длительность выдерживани перед употреблением те же, что и дл раствор-а витаминов .The shelf life and durability before use are the same as for the solution of vitamins.
При испытании культуральных свойств предлагаемой поддерживающей среды с использованием в качестве тест-объектов перманентных клеток СОЦ, перманентных клеток амниона человека и первично трипсинизированных клеток эмбриона человека сроки переживани составили соответственно 14-18, 14-17 и 16-21 день. В случае отсутстви в описываемой поддерживаюш,ей среде иуклиеновокислого патри клетки переживали не более 7 дней.When testing the cultural properties of the proposed supportive environment using as a test object of permanent cells of SOC, permanent cells of human amnion and primary trypsinized cells of a human embryo, the periods of experience were 14-18, 14-17 and 16-21 days, respectively. In case of absence in the described support, her environment and the acid-acidic patri cell survived no more than 7 days.
Предмет изобрете 1и The subject invention 1i
Питательна безбелкова поддерживающа среда дл животных клеток, выращиваемых in vitro, состо ща из белкового гидролизата, солевого раствора, витаминов, отличающа с тем, что, с целью удлинени сроков переживани клеток, в ее состав ввод т нуклеиновокислый натрий.A nutrient-free protein-free support for animal cells grown in vitro, consisting of protein hydrolyzate, saline, vitamins, characterized in that nucleic sodium is introduced into its composition in order to prolong the cell survival time.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU162294A1 true SU162294A1 (en) |
Family
ID=
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8986957B2 (en) | 2010-04-26 | 2015-03-24 | Novartis Ag | Cell culture medium |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8986957B2 (en) | 2010-04-26 | 2015-03-24 | Novartis Ag | Cell culture medium |
| RU2563353C2 (en) * | 2010-04-26 | 2015-09-20 | Новартис Аг | Improved cell culture medium |
| US9243224B2 (en) | 2010-04-26 | 2016-01-26 | Novartis Ag | Cell culture medium |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weiss | Growth and physiology of rickettsiae | |
| Morgan et al. | Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. | |
| Eagle | Amino acid metabolism in mammalian cell cultures | |
| Van Winkle et al. | Glycine protects preimplantation mouse conceptuses from a detrimental effect on development of the inorganic ions in oviductal fluid | |
| Redondo‐Müller et al. | In vitro maturation of the potential for movement of carp spermatozoa | |
| Hazel | Thermal adaptation in biological membranes: is homeoviscous adaptation the explanation? | |
| US6730315B2 (en) | Medium and matrix for long-term proliferation of cells | |
| US8071281B2 (en) | Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens | |
| ES2197140T3 (en) | PHYSIOLOGICAL ENVIRONMENT FOR THE PERFUSION, CONSERVATION AND STORAGE OF SAMPLES OF CELLS, FABRICS AND ISOLATED ORGANS. | |
| Brinster | In vitro culture of mammalian embryos | |
| SU162294A1 (en) | ||
| EP0082974B1 (en) | Method for the cultivation of normal diploid cells and cultivation medium used therefor | |
| Pace et al. | Effects of oxygen on growth in several established cell lines | |
| Tiruppathi et al. | Constitutive expression of the taurine transporter in a human colon carcinoma cell line | |
| Zigman et al. | A cold precipitable protein in the lens | |
| Krayushkina et al. | Osmotic and ion regulation in different species of acipenserids (Acipenseriformes, Acipenseridae) | |
| Metzgar Jr et al. | Separation of Growth Promoting Activity from Horse Serum by Dialysis. | |
| Mitsuhashi | Continuous cultures of insect cell lines in media free of sera | |
| Luh et al. | The effects of hyperosmolarity on the viability and function of endothelial cells | |
| Popp | Comparative metabolism of blastocysts, extraembryonic membranes, and uterine endometrium of the mouse | |
| Murad et al. | Serum stimulation of lysyl hydroxylase activity in cultured human skin fibroblasts | |
| de Bruyn | LYMPHOSARCOMA MB (T86157) WITHOUT TYPICAL | |
| CN114836373A (en) | Oocyte activation culture medium and culture method and application thereof | |
| Lawson | Growth of cariogenic streptococci in chemically defined medium | |
| ES2250223T3 (en) | ADHERENT ANIMAL CELL PRODUCTION METHOD. |